Literature DB >> 9717782

Intraductal papillary tumors of the pancreas: evaluation with endoscopic ultrasonography.

M Sugiyama1, Y Atomi, M Saito.   

Abstract

BACKGROUND: We retrospectively analyzed the endoscopic ultrasonographic characteristics of intraductal papillary tumors of the pancreas and identified signs indicative of malignant tumors.
METHODS: Twenty-eight patients with intraductal tumors and 38 with other pancreatic cystic lesions underwent endoscopic ultrasonography, conventional ultrasonography, and endoscopic retrograde cholangiopancreatography (ERCP).
RESULTS: Intraductal tumors were classified into three subtypes, and endoscopic ultrasonographic characteristics were assessed. In main duct type tumors, the main pancreatic duct showed a segmental or diffuse moderate-to-marked dilatation, often associated with intraductal nodules. Pancreatic parenchymal atrophy was frequently recognized. Branch duct type tumors consisted of multiple 5 to 20 mm cysts with the appearance of a cluster of grapes. The main duct was mildly dilated or nondilated. Combined type tumors had features of both main duct and branch duct types. Endoscopic ultrasonography (92%) differentiated pancreatic cystic lesions more precisely than ultrasonography (82%) and ERCP (89%). Main duct or combined type tumors, large tumors (> or = 30 mm for branch duct type), marked dilatation of the main pancreatic duct (> or = 10 mm for other types), and mural nodules suggested malignancy. Endoscopic ultrasonography demonstrated these signs more accurately than ultrasonography or ERCP.
CONCLUSION: Endoscopic ultrasonography is useful for diagnosing intraductal papillary tumors, particularly for predicting malignancy.

Entities:  

Mesh:

Year:  1998        PMID: 9717782     DOI: 10.1016/s0016-5107(98)70158-0

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  12 in total

Review 1.  Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  Go Kobayashi; Naotaka Fujita; Yutaka Noda; Takashi Obana; Osamu Takasawa
Journal:  J Med Ultrason (2001)       Date:  2008-09-19       Impact factor: 1.314

2.  Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.

Authors:  Hirofumi Harima; Seiji Kaino; Shuhei Shinoda; Michitaka Kawano; Shigeyuki Suenaga; Isao Sakaida
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

3.  Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS.

Authors:  Go Kobayashi; Naotaka Fujita; Yutaka Noda; Kei Ito; Jun Horaguchi; Osamu Takasawa; Satoshi Akaishi; Takashi Tsuchiya; Masao Kobari
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

Review 4.  [Cystic lesions of the pancreas].

Authors:  U Rosien; P Layer
Journal:  Med Klin (Munich)       Date:  1999-07-15

5.  Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate?

Authors:  Roberto Salvia; Stefano Crippa; Massimo Falconi; Claudio Bassi; Alessandro Guarise; Aldo Scarpa; Paolo Pederzoli
Journal:  Gut       Date:  2006-11-24       Impact factor: 23.059

6.  Main-duct intraductal papillary mucinous adenoma of the pancreas with a large mural nodule.

Authors:  Koki Nagaike; Kazuo Chijiiwa; Masahide Hiyoshi; Jiro Ohuchida; Hiroaki Kataoka
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

Review 7.  Comparison of ERCP, EUS, and ERCP combined with EUS in diagnosing pancreatic neoplasms: a systematic review and meta-analysis.

Authors:  Hongyu Li; Zhigang Hu; Jiang Chen; Xiaozhong Guo
Journal:  Tumour Biol       Date:  2014-06-03

Review 8.  ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts.

Authors:  Grace H Elta; Brintha K Enestvedt; Bryan G Sauer; Anne Marie Lennon
Journal:  Am J Gastroenterol       Date:  2018-02-27       Impact factor: 10.864

Review 9.  Management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masanori Sugiyama; Yutaka Suzuki; Nobutsugu Abe; Toshiyuki Mori; Yutaka Atomi
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

10.  Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Kennichi Satoh; Shin Hamada; Atsushi Kanno; Morihisa Hirota; Jun Umino; Hiromichi Ito; Atsushi Masamune; Shinichi Egawa; Michiaki Unno; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2010-01-28       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.